On Wednesday, October 5, the World Health Organization (WHO) announced that it is looking into “contaminated” medications, primarily for pediatric use, that have been found to contain dangerous substances due to Cough Syrup 66 Kids Death.
Cough Syrup 66 Kids Death
The WHO has warned that they may be responsible for the deaths of 66 children in The Gambia, a country in west Africa.
Indian company Maiden Pharmaceuticals Limited makes cough and cold syrups.
The WHO stated the following in a series of tweets, quoting its Director-General Tedros Adhanom Ghebreyesus: “WHO has today released a medical product alert for four tainted medications that have been discovered in #Gambia and may be associated with acute renal injuries and 66 child fatalities. For the relatives of these children, the loss of their young lives is unbearably tragic.”
It continued, “The four medications are syrups for colds and coughs made by the Indian company Maiden Pharmaceuticals Limited. In collaboration with the company and Indian regulatory bodies, WHO is conducting additional research.”
Additionally, Tedros stated that the WHO was “doing a further investigation with the company and regulatory authorities in India.”
According to the WHO advisory, the four items are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup.
“To yet, the claimed producer has not offered guarantees to WHO on the safety and quality of these items,” the WHO added. The items “prove that they contain excessive concentrations of diethylene glycol and ethylene glycol as impurities,” it was stated. Laboratory investigation of product samples.
According to the warning, hazardous substances can kill people. In addition to severe kidney injury, which may result in death, the toxic impact “may include abdominal discomfort, vomiting, diarrhea, inability to pass urine, headache, changed mental status, and other symptoms.”
The company had only given the harmful pharmaceuticals to The Gambia, according to information from India’s Central Drugs Standard Control Organization, according to the WHO.